SynBiotic SE

SynBiotic SE

News

18.12.2024 13:06:47

EQS-News: Trend-setting decontamination: SYNBIOTIC and GOC NEXUS set the gold standard for cannabis

18.12.2024 09:01:01

Original-Research: SYNBIOTIC SE (von NuWays AG): BUY

25.11.2024 11:39:58

EQS-News: SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry

14.11.2024 13:30:41

EQS-News: In full bloom: WEECO Pharma boosts SYNBIOTIC's sales

27.09.2024 11:19:23

EQS-News: Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval

17.09.2024 09:01:14

Original-Research: SynBiotic SE (von NuWays AG): BUY

16.08.2024 12:30:07

EQS-News: SYNBIOTIC Annual General Meeting on 20.09.2024: Increasing sales drive growth

23.05.2024 10:31:25

EQS-News: Berlin, Prague, Berlin: SYNBIOTIC and CEO Daniel Kruse on roadshow

08.05.2024 14:27:26

EQS-News: Acquisition of WEECO Pharma: SYNBIOTIC significantly expands its position in the medical cannabis market

25.04.2024 12:33:59

EQS-News: 1.6 million euros for Hanf Farm: Federal Ministry for Economic Affairs and Climate Protection funds bio-economy project

Downloads

Latest Research

Initiation

Analyst

Christian Sandherr

Equity Research

Latest Research

Christian Sandherr

December 18 2024

18 Dec 24

The new group continues to take shape; chg. est.

Christian Sandherr

September 17 2024

17 Sep 24

SynBiotic transformation: Reaching new operational high(t)s

Christian Sandherr

August 29 2023

29 Aug 23

Gearing up to capitalize on favorable market dynamics; chg.

Christian Sandherr

December 28 2022

28 Dec 22

Strategic realignment to capitalize on cannabis legalization; chg.